New Advances in Nanomaterials for Biomedical Diagnostics and Therapy

A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Materials Processes".

Deadline for manuscript submissions: 10 April 2025 | Viewed by 668

Special Issue Editor


E-Mail Website
Guest Editor
Mckelvey School of Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA
Interests: regenerative medicine; polymeric biomaterials; vessel-on-chip; artery calcification

Special Issue Information

Dear Colleagues,

In the dynamic landscape of biomedical research, nanomedicine captivates global attention for its remarkable capabilities. Imagine cost-effective, rapid, and highly specific solutions that can transform medical challenges into triumphs. The nanomedicine market is set to surge from USD 174.13 billion in 2022 to approximately USD 564.15 billion by 2032. At the forefront of this revolution is the profound impact of nanotechnology on medical diagnostics, immunization, and various therapies. The flexibility of nanomaterials to couple with various substances opens doors to a realm of possibilities. Whether through chemical conjugation, physical encapsulation, or adsorption, these loaded nanosubstances pave the way for the targeted delivery of drugs, chemotherapeutic agents, imaging substances, or vital biological entities.

This Special Issue is dedicated to showcasing a collection of studies centered on the latest advancements in nanomaterials tailored for diverse applications in biomedical tracking, detection, and treatment across various scenarios. Researchers from a wide array of disciplines are encouraged to submit manuscripts, exploring areas such as:

  1. Development of nanomaterials for diagnosing cancer and chronic diseases.
  2. Therapeutic treatments using both loaded and non-loaded nanomaterials.
  3. Integration of nanotechnology with other methods for tissue regeneration.
  4. Development of nanomaterials for immunization and vaccine production.
  5. Innovative approaches to synthesize, fabricate, and characterize nanomaterials.

Dr. Hong Niu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomaterials
  • nanomedicine
  • diagnostics
  • drug delivery
  • tissue regeneration

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 3971 KiB  
Review
Recent Progress in Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Drug Delivery Carriers for Pain Management
by Tao Liang, Jingjing Gao, Ruiquan Feng, Yu Zheng, Kewei Tian, Jianer Chen and Xiaoling Xu
Processes 2024, 12(7), 1372; https://doi.org/10.3390/pr12071372 - 1 Jul 2024
Viewed by 467
Abstract
Pain, a prevalent clinical symptom, significantly demands attention in the current public health system due to its profound impact on patients’ quality of life, daily activities, and economic circumstances. Despite being a pervasive issue, many forms of pain remain ineffectively addressed, hence posing [...] Read more.
Pain, a prevalent clinical symptom, significantly demands attention in the current public health system due to its profound impact on patients’ quality of life, daily activities, and economic circumstances. Despite being a pervasive issue, many forms of pain remain ineffectively addressed, hence posing an enormous burden on patients. Pharmaceutical treatments, the first-line approach for various forms of pain, continue to face considerable challenges due to their limited efficacy, lack of long-lasting effects, and adverse side effects. In recent years, the rapid advancements in science and technology, especially the incorporation of micro and nano technologies across various domains, have accelerated the development of novel therapeutics. This review underscores the merits and drawbacks of different pharmacological strategies for pain management. It focuses on the research progress and applications of poly (lactic-co-glycolic acid)(PLGA) as drug delivery carriers, elucidating their potential therapeutic influence over pain management. The review concludes with a thorough summary of current research outcomes and limitations, a discussion of potential clinical transformations, and projections for future pain management research and effective care strategies. Full article
(This article belongs to the Special Issue New Advances in Nanomaterials for Biomedical Diagnostics and Therapy)
Show Figures

Graphical abstract

Back to TopTop